It is quite disheartening to listen to some states complaining about Bharat Biotech’s intentions regarding supply of Covid-19 vaccine Covaxin, a top company official said on Wednesday.
In a tweet, Bharat Biotech Joint Managing Director Suchitra Ella said that the company has already dispatched Covaxin lots to 18 states on 10 May. “18 states have been covered though in smaller shipments. Quite disheartening to the teams to hear some states complaining about our intentions. 50 of our employees are off work due to covid, yet we continue to work under pandemic lockdowns 24×7 for U,” she said in a tweet.
Hyderabad-based Bharat Biotech is supplying Covaxin to 18 states, including Andhra Pradesh, Haryana, Odisha, Assam, Jammu & Kashmir, Tamil Nadu, Bihar, Jharkhand and Delhi. Other states include Chhattisgarh, Karnataka, Telangana, Tripura, Madhya Pradesh, Uttar Pradesh, Gujarat, Maharashtra and West Bengal.
Earlier, Delhi Deputy CM Manish Sisodia said that Bharat Biotech has informed the state government that it cannot provide “additional” Covaxin doses to the national capital. The stock of Covaxin in Delhi has finished and as a result around 100 vaccination centres set up in 17 schools have been closed, he said.